REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Remegen Co., Ltd. Profile Updated: March 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

RemeGen Co., Ltd is a biopharmaceutical company that has developed a product pipeline with innovative drugs in the R&D and commercialization stages. RemeGen has obtained a global licensing agreement for a drug with Seagen, a biopharmaceutical company, excluding the Asia Pacific region.

Headquarters
No. 58, Beijing Middle Road, Yantai Development Zone, Yantai Area, China (Shandong) Pilot Free Trade Zone, Shandong Province
Yantai; Shandong; Postal Code: 264006

Contact Details: Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.

Website: http://www.remegen.cn

Basic Information
Total Employees:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Registered Capital:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Financial Auditors:
Purchase the Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report to view the information.
Incorporation Date:
July 04, 2008
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
34.83%
Purchase this report to view the information.
18.81%
Purchase this report to view the information.
4.82%
Purchase this report to view the information.
3.4%
Purchase this report to view the information.
3.06%
Subsidiaries
RemeGen Australia Pty Ltd
100%
Remegen Biosciences, Inc.
100%
Rongchang Bio-Hong Kong Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Remegen Co., Ltd. (荣昌生物制药(烟台)股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
42.27%▲
Total operating revenue
41.67%▲
Operating Profit/Loss (EBIT)
49.12%▲
Net Profit/Loss for the Period
48.6%▲
Total Assets
4.63%▲
Total Equity
-2.05%▼
Operating Profit Margin (ROS)
56.1%▲
Net Profit Margin
56.61%▲
Return on Equity (ROE)
21.49%▲
Debt/Equity
-23.78%▼
Quick Ratio
-0.23%▼
Cash Ratio
0.02%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
JD Health International Inc.
Nanjing Pharmaceutical Group Company Limited
 
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (上海复星医药(集团)股份有限公司)
Beijing Strong Biotechnologies,Inc.
 
Liaoning Chengda Biotechnology Co.,Ltd.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (Hangzhou) (江苏诺泰澳赛诺生物制药股份有限公司 (杭州))
 
Sunshine Guojian Pharmaceutical(Shanghai)Co., Ltd. (三生国健药业(上海)股份有限公司)
Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo